Germany
Japan
United Kingdom
China
Recombinant Anti-CTLA-4 (Clone 9D9)
| Applications | IF |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Antibodies
View as table DownloadRecombinant Anti-CD86 (Clone PO.3)
| Applications | Bl, FC, IHC, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD153 (Clone RM153)
| Applications | Bl, FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-IL-6R (Clone D7715A7)
| Applications | Bl, FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-IL-9 (Clone MH9A4)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD226 (Clone 10E5)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-IL2R gamma C (Clone 3E12)
| Applications | Bl, FC, IP |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
USD 523.00
2 Weeks
Recombinant Anti-GABAR (Clone 1F4)
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD37 (Clone IPO-24 (ZC37-24))
| Applications | FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD43 (Clone 84-3C1)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CCR5 (phosphoserine 337) (Clone V14/2)
| Applications | ELISA, FC, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-IL-8RA (Clone SE2)
| Applications | FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-H3K27me3 (Clone BT164)
| Applications | ELISA, ICC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD32 (Clone IV.3)
| Applications | ELISA, IF, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Mesothelin (Clone 11-25)
| Applications | ELISA, FC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Isotypes
- IgG2b, kappa
Conjugates
- Unconjugated
Filter by
Target Symbol
- EBI3 (4)
- MAVS (3)
- CD1A (2)
- CD52 (2)
- ERBB2 (2)
- FITC (2)
- HIS (2)
- HSPB1 (2)
- IL17RA (2)
- MYC (2)
- SALL4 (2)
- TMBIM6 (2)
- V5 (2)
- ACP5 (1)
- ACTB (1)
- ADGRE1 (1)
- APIP (1)
- ARHGDIB (1)
- B2M (1)
- BRCA1 (1)
- CALD1 (1)
- CCR3 (1)
- CCR5 (1)
- CD16 (FCGR3A) (1)
- CD2 (1)
- CD226 (1)
- CD37 (1)
- CD7 (1)
- CD74 (1)
- CD79A (1)
- CD86 (1)
- CD8A (1)
- CD8B1 (1)
- CDKN1C (1)
- CHRNA1 (1)
- CIP2A (1)
- CLDN4 (1)
- CR2 (1)
- CRLF2 (1)
- CTLA4 (1)
- CXCR1 (1)
- CYCS (1)
- CYP8B1 (1)
- DDIT3 (1)
- EPCAM (1)
- FCGR2A (1)
- GABRA1 (1)
- GCG (1)
- GFAP (1)
- H3 (1)
- HIST3H3 (1)
- HMGB1 (1)
- HNRNPM (1)
- IGF2 (1)
- IL17A (1)
- IL27RA (1)
- IL2RG (1)
- IL6RA (1)
- IL9 (1)
- INS (1)
- ITGAM (1)
- KAT2B (1)
- KERATIN (1)
- LIF (1)
- LTA (1)
- MAGEC1 (1)
- MGST1 (1)
- MHC I (1)
- MHC II (1)
- MLANA (1)
- MSLN (1)
- MUC2 (1)
- MUC4 (1)
- NLRP3 (1)
- NT5E (1)
- PARP1 (1)
- PCLO (1)
- PHB (1)
- PRC1 (1)
- S (1)
- S100A8 (1)
- SARS (1)
- SF3B4 (1)
- SPN (1)
- SSRP1 (1)
- SST (1)
- STMN1 (1)
- TAOK1 (1)
- TIMP2 (1)
- TLR4 (1)
- TNFRSF8 (1)
- TNFSF18 (1)
- TNFSF8 (1)
- TP53 (1)
- TPO (1)
- TUBG1 (1)
- UBA6 (1)
- YWHAZ (1)
Reactivities
Applications
Antibody Hosts
Clonalities
Modifications
- This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. (4)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (1)
- This is a chimeric antibody created to reduce immunogenicity during in vivo applications. (1)
Assay Types
Families
Pathways
- Cytokine-cytokine receptor interaction (5)
- MAPK signaling pathway (5)
- Pathways in cancer (4)
- Bladder cancer (3)
- Cell cycle (3)
- Cytosolic DNA-sensing pathway (3)
- Endometrial cancer (3)
- Neurotrophin signaling pathway (3)
- Non-small cell lung cancer (3)
- Pancreatic cancer (3)
- Prostate cancer (3)
- RIG-I-like receptor signaling pathway (3)
- Adherens junction (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Apoptosis (2)
- Base excision repair (2)
- Calcium signaling pathway (2)
- Colorectal cancer (2)
- ErbB signaling pathway (2)
- Focal adhesion (2)
- Huntington's disease (2)
- Jak-STAT signaling pathway (2)
- Metabolic pathways (2)
- Pathogenic Escherichia coli infection (2)
- Small cell lung cancer (2)
- Spliceosome (2)
- Ubiquitin mediated proteolysis (2)
- VEGF signaling pathway (2)
- p53 signaling pathway (2)
- Alzheimer's disease (1)
- Aminoacyl-tRNA biosynthesis (1)
- Basal cell carcinoma (1)
- Chronic myeloid leukemia (1)
- Cysteine and methionine metabolism (1)
- Glioma (1)
- Lysosome (1)
- Melanoma (1)
- NOD-like receptor signaling pathway (1)
- Notch signaling pathway (1)
- Oocyte meiosis (1)
- PPAR signaling pathway (1)
- Parkinson's disease (1)
- Primary bile acid biosynthesis (1)
- Riboflavin metabolism (1)
- Systemic lupus erythematosus (1)
- Thyroid cancer (1)
- Toll-like receptor signaling pathway (1)
- Viral myocarditis (1)
- Wnt signaling pathway (1)